Institute for Infection Prevention and Control & Center for Chronic Immunodeficiency (CCI)
Medical Center – University of Freiburg
Breisacher Str. 117
79106 Freiburg
- +49 (0)761 270-77640
- philipp.henneke@uniklinik-freiburg.de
- Homepage
Current position
W3 Professor of Infection Immunity and Control, Institute for Infection Prevention and Control &
Institute for Immunodeficiency, Center for Chronic Immunodeficiency,
Medical Center – University of Freiburg
Academic training
| 1987 - 1994 | Medical studies at Freie Universität, Berlin |
Scientific qualifications
| 2005 | Habilitation, Faculty of Medicine, University of Freiburg |
| 1995 | Dissertation in Medicine, Freie Universität Berlin |
Postgraduate positions
| since 2023 | W3-Professor, Director, Institute for Infection Prevention and Control, Medical Center - University of Freiburg |
| 2012 | W3 Professor Infection and Immunity, Head of Section for Pediatric Infectious Diseases and Rheumatology, CCI and Center for Pediatrics, Medical Center - University of Freiburg |
| 2008 - 2012 | Tenure Track Infection and Immunity and group leader, CCI Freiburg |
| 2005 - 2012 | Attending Physician (“Oberarzt”) in Pediatric Infectious Diseases and Immunology, Center of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg |
| 2003 - 2009 | Assistant Prof. (“Juniorprofessor”) in Pediatric Infectious Diseases, Medical Center - University of Freiburg |
| 2001 - 2002 | Lecturer, Harvard Medical School, USA |
| 2001 - 2002 | Instructor/ Assistant Prof. in Medicine, Univ. of Massachusetts, Worcester, USA |
| 1999 - 2001 | Postdoc at Division of Infectious Dis. and Immunology, Boston University, USA |
| 1994 - 1999 | Registrar in Pediatrics, Children’s Hospital, Freie Universität Berlin |
Miscellaneous (Honors, Awards)
| since 2023 | CRC/TRR "PILOT", Speaker |
| since 2013 | Coordinator Research Committee, ESPID |
| 2009 | Call W3-Professorship in Infection and Immunology, Tübingen Univ. (declined) |
| 2008 | Research Award, German Soc. of Pediatric Infectious Diseases |
| 2007 | Research Award, German Soc. of Neonatology and Pediatric Intensive Care |
| 2003 | Hugo-Schottmüller-Preis, German Sepsis Society |
| 2003 | Young Investigator Award, European Society of Pediatric Infectious Diseases |
link to all publications from P. Henneke: Pubmed
Publications based on CRC1160 funding
Gres V, Göcer M, Kolter J, Henneke P. 2025. Trained immunity in skin infections: Macrophages and beyond. Elife. 14:e106688. doi: 10.7554/eLife.106688.
Kolter J, Döring CL, Sarout S, Baasch S, Steele L, Alsumati R, Lucena Silva GV, Aníbal Silva CE, Paiva IM, Mansoori Moghadam Z, Gres V, Lohrmann F, Aktories P, Buchegger T, Bijnen M, Doumard L, Voisin B, Le Foll C, Lachmann N, Greter M, Kierdorf K, Haniffa M, Cunha TM, Flacher V, Henneke P. 2025. Sensory neurons shape local macrophage identity via TGF-β signaling. Immunity. 2025 Sep 5:S1074-7613(25)00367-X. doi: 10.1016/j.immuni.2025.08.004.
Seidl M, Haghighi EB, Lösslein AK, Hufnagel M, Lohrmann F, Schneider C, Kohlfürst DS, Zenz W, Gorkiewicz G, Feiterna-Sperling C, Krüger R, Bronsert P, Neppl C, Sommer KZ, Stehl V, Boerries M, Kuntz M, Henneke P. 2025. Immunopathogenic and clinical implications of advanced tissue analysis in non-tuberculous mycobacterial infections in children. Front Immunol. 16:1597074. doi: 10.3389/fimmu.2025.1597074.
Lösslein AK, Henneke P. 2025. Macrophage Differentiation and Metabolic Adaptation in Mycobacterial Infections. 2025. Annu Rev Immunol. doi: 10.1146/annurev-immunol-082323-120757.
Mansoori Moghadam Z, Zhao B, Raynaud C RWTH University Hospital, Strohmeier V, Neuber J, Lösslein AK, Qureshi S, Gres V, Ziegelbauer T, Baasch S, Schell C, Warnatz K, Inohara N, Nunez G, Clavel T, Rosshart SP, Kolter J, Henneke P. 2025. Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface. Blood. blood.2024025240. doi: 10.1182/blood.2024025240.
Vinnakota JM, Biavasco F, Schwabenland M, Chhatbar C, Adams RC, Erny D, Duquesne S, El Khawanky N, Schmidt D, Fetsch V, Zähringer A, Salié H, Athanassopoulos D, Braun LM, Javorniczky NR, Ho JNHG, Kierdorf K, Marks R, Wäsch R, Simonetta F, Andrieux G, Pfeifer D, Monaco G, Capitini C, Fry TJ, Blank T, Blazar BR, Wagner E, Theobald M, Sommer C, Stelljes M, Reicherts C, Jeibmann A, Schittenhelm J, Monoranu CM, Rosenwald A, Kortüm M, Rasche L, Einsele H, Meyer PT, Brumberg J, Völkl S, Mackensen A, Coras R, von Bergwelt-Baildon M, Albert NL, Bartos LM, Brendel M, Holzgreve A, Mack M, Boerries M, Mackall CL, Duyster J, Henneke P, Priller J, Köhler N, Strübing F, Bengsch B, Ruella M, Subklewe M, von Baumgarten L, Gill S, Prinz M, Zeiser R. 2024. Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nat Cancer. May 13. doi: 10.1038/s43018-024-00764-7.
